Related Experiment Video
Updated: Aug 25, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Epigenetic inactivation of TMS1/ASC in ovarian cancer
Katsuhiko Terasawa1, Satoru Sagae, Minoru Toyota
1Departments of Obstetrics and Gynecology, Sapporo Medical University, Sapporo, Japan. kterasaw@sapmed.ac.jp
Purpose:
The purpose of this work was to explore the role of epigenetic inactivation of apoptotic pathways in ovarian cancer by examining the DNA methylation and expression status of four proapoptotic genes in primary ovarian cancers and cancer cell lines and to correlate those findings with the clinicopathological features of ovarian cancer patients.
Experimental Design:
Genomic DNA was isolated from 15 ovarian cancer cell lines, 80 primary ovarian cancer specimens, and 4 normal ovary specimens using phenol-chloroform extraction. The methylation status of the DNA was evaluated using combined bisulfite restriction analysis, gene expression was evaluated using reverse transcription-PCR, and histone acetylation was evaluated using chromatin immunoprecipitation.
Results:
Of the four proapoptotic genes studied, expression of TMS1/ASC was absent in six ovarian cancer cell lines. Dense methylation of the 5' region of TMS1/ASC was detected in cells not expressing TMS1/ASC. Treating methylated cells with 5-aza-deoxycytidine restored gene expression, confirming the role of methylation in silencing the gene. Chromatin immunoprecipitation revealed histone to be deacetylated in cells not expressing TMS1/ASC, indicating that histone deacetylation is also involved in silencing TMS1/ASC. Aberrant methylation of TMS1/ASC was detected in 15 of 80 ovarian cancer tissues (19%) but in none of the normal ovary specimens. Aberrant methylation of TMS1/ASC was observed significantly more often in clear cell-type ovarian cancers than in other tumor types (P < 0.0001).
Conclusions:
Methylation-mediated silencing of TMS1/ASC confers a survival advantage to tumor cells by enabling them to escape apoptosis. The role for aberrant methylation in human ovarian tumorigenesis may be particularly important for ovarian cancers with the clear cell phenotype.
Insights
Epigenetic silencing of the TMS1/ASC gene through DNA methylation and histone deacetylation promotes ovarian cancer cell survival. Aberrant methylation of TMS1/ASC is common in ovarian tumors, especially clear cell types.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Ovarian cancer progression involves complex genetic and epigenetic alterations.
- Apoptotic pathways are frequently dysregulated in cancer, contributing to tumor cell survival.
- Epigenetic silencing of tumor suppressor genes is a key mechanism in tumorigenesis.
Purpose of the Study:
- To investigate the epigenetic inactivation of apoptotic pathways in ovarian cancer.
- To examine DNA methylation and gene expression of proapoptotic genes in ovarian cancers.
- To correlate epigenetic alterations with clinicopathological features of ovarian cancer patients.
Main Methods:
- DNA methylation analysis using combined bisulfite restriction analysis.
- Gene expression profiling via reverse transcription-polymerase chain reaction (RT-PCR).
- Histone acetylation assessment using chromatin immunoprecipitation.
Main Results:
- TMS1/ASC gene expression was absent in 6/15 ovarian cancer cell lines.
- Dense DNA methylation and histone deacetylation were associated with TMS1/ASC silencing.
- Aberrant TMS1/ASC methylation occurred in 19% of primary ovarian cancers, significantly higher in clear cell types.
Conclusions:
- Methylation-mediated silencing of TMS1/ASC enables ovarian cancer cells to evade apoptosis, conferring a survival advantage.
- Aberrant methylation of TMS1/ASC plays a significant role in ovarian tumorigenesis, particularly in clear cell ovarian cancers.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation
X-chromosome...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
